Oral Anticoagulation for Primary Prophylaxis of Venous Thromboembolism in Patients with Cancer

被引：0
|
作者：
Aronow, Wilbert S. [1 ]
Shamliyan, Tatyana A. [2 ]
机构：
[1] New York Med Coll, Westchester Med Ctr, New York, NY USA
[2] Elsevier, Evidence Based Med Ctr, Qual Assurance, Philadelphia, PA USA
来源：
AMERICAN JOURNAL OF MEDICINE | 2018年 / 131卷 / 08期
关键词：
CLINICAL-PRACTICE GUIDELINES; SMALL CELL-CARCINOMA; RANDOMIZED-TRIAL; EUROPEAN GUIDELINES; AMERICAN SOCIETY; LUNG-CANCER; PREVENTION; WARFARIN; THROMBOPROPHYLAXIS; CHEMOTHERAPY;
D O I：
10.1016/j.amjmed.2018.02.029
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：902 / 907
页数：6
相关论文
共 50 条
  • [41] Prophylaxis and Treatment of Venous Thromboembolism in Cancer Patients A Review
    Ansell, Jack E.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (04): : S8 - S12
  • [42] Prophylaxis against Venous Thromboembolism in Ambulatory Patients with Cancer
    Connors, Jean M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (26): : 2515 - 2519
  • [43] Treatment and secondary prophylaxis of venous thromboembolism in cancer patients
    Ali, Nadeen T.
    Young, Annie
    SUPPORTIVE CARE IN CANCER, 2022, 30 (10) : 8519 - 8526
  • [44] Risk of venous thromboembolism and primary prophylaxis in cancer Should all patients receive thromboprophylaxis?
    Pabinger, I.
    Ay, C.
    HAMOSTASEOLOGIE, 2012, 32 (02): : 132 - 137
  • [45] Safety of Heparin for Prophylaxis of Venous Thromboembolism in Oral Anticoagulation-Associated Intracerebral Hemorrhage.
    Sembill, Jochen A.
    Sprugel, Maximilian, I
    Kuramatsu, Joji B.
    Gerner, Stefan T.
    Dorfler, Arnd
    Schwab, Stefan
    Huttner, Hagen
    STROKE, 2019, 50
  • [46] Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
    Robertson, Lindsay
    Yeoh, Su Ern
    Ram, Ahmad
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (12):
  • [47] Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer
    Akl, E. A.
    Barba, M.
    Rohilla, S.
    Terrenato, I
    Sperati, F.
    Muti, P.
    Schuenemann, H. J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02):
  • [48] Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative
    Barkoudah, Ebrahim
    Piazza, Gregory
    Hecht, Todd E. H.
    Grant, Paul
    Deitelzweig, Steven
    Fang, Margaret C.
    Fanikos, John
    Kao, Cheng-Kai
    Barnes, Geoffrey D.
    Chen, Thomas
    Ramishvili, Tea
    Schnipper, Jeffrey L.
    Goldstein, Jennifer N.
    Ruff, Christian T.
    Kaatz, Scott
    Schwartz, Aviva
    Connors, Jean M.
    Goldhaber, Samuel Z.
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 : 1 - 27
  • [49] Low dose rivaroxaban for secondary prophylaxis after full anticoagulation in patients with venous thromboembolism
    Zhou, A.
    Chan, A. K.
    Lau, K. K.
    Chan, H. H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 637 - 638
  • [50] Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters
    Akl, E. A.
    Karmath, G.
    Yosuico, V
    Kim, S. Y.
    Barba, M.
    Sperati, F.
    Cook, D.
    Schuenemann, H. J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (03):
12345